Arthur G. Palmer and Oliver Hobert of the Department of Biochemistry & Molecular Biophysics were selected in recognition of their distinguished and continuing achievements in research.
A study co-led by Columbia scientists suggests a nutrient transporter located at the blood-brain barrier could be commandeered to sneak therapeutic drugs into the brain.
Columbia researchers have found that cells inside clogged arteries have cancer-like properties that aggravate atherosclerosis, and anticancer drugs could be a new treatment.
CUIMC researchers are helping scientists change the way they study human behavior to focus on the mechanisms that explain how people adopt healthier habits.
A new optical imaging system developed at Columbia University uses red and near-infrared light to identify breast cancer patients who will respond best to chemotherapy.
Neurons mature and acquire their firing properties with the help of Rbfox genes, a family of genes linked to autism and other neurodevelopmental disorders.
Columbia neurologists and engineers are using a robotic device to investigate how Parkinson’s affects the ability to walk and respond to balance perturbations.
Using electron microscopy, CUIMC biologists have captured the first detailed images of a calcium membrane pore in action, revealing a potential target for treating cancer.
At TED 2017, CUMC radiation scientist David Brenner discussed his work using physics to create a new, potentially life-saving weapon against drug-resistant microbes.